Business Description
Regencell Bioscience Holdings Ltd
NAICS : 325412
SIC : 2834
Description
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | N/A |
N/A
|
N/A
| |||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-EBITDA | -0.11 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -160.5 | |||||
| 3-Year EPS without NRI Growth Rate | -165.5 | |||||
| 3-Year FCF Growth Rate | -147.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.81 | |||||
| 9-Day RSI | 61.79 | |||||
| 14-Day RSI | 55.48 | |||||
| 6-1 Month Momentum % | -42.47 | |||||
| 12-1 Month Momentum % | -53.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1 | |||||
| Shareholder Yield % | 0.8 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -41.31 | |||||
| ROA % | -38.89 | |||||
| ROIC % | -57.43 | |||||
| ROC (Joel Greenblatt) % | -63.95 | |||||
| ROCE % | -41.01 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 15.04 | |||||
| Price-to-Tangible-Book | 15.04 | |||||
| EV-to-EBIT | -24.76 | |||||
| EV-to-EBITDA | -26.9 | |||||
| EV-to-FCF | -28.07 | |||||
| Price-to-Net-Current-Asset-Value | 16.67 | |||||
| Earnings Yield (Greenblatt) % | -4.04 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RGC
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Regencell Bioscience Holdings Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.54 | ||
| Beta | 0 | ||
| Volatility % | 35.97 | ||
| 14-Day RSI | 55.48 | ||
| 14-Day ATR ($) | 0.91536 | ||
| 20-Day SMA ($) | 14.28019 | ||
| 12-1 Month Momentum % | -53.18 | ||
| 52-Week Range ($) | 10.7 - 33.82 | ||
| Shares Outstanding (Mil) | 13.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Regencell Bioscience Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Regencell Bioscience Holdings Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Regencell Bioscience Holdings Ltd Frequently Asked Questions
What is Regencell Bioscience Holdings Ltd(RGC)'s stock price today?
The current price of RGC is $17.00. The 52 week high of RGC is $33.82 and 52 week low is $10.70.
When is next earnings date of Regencell Bioscience Holdings Ltd(RGC)?
The next earnings date of Regencell Bioscience Holdings Ltd(RGC) is 2023-11-15 Est..
Does Regencell Bioscience Holdings Ltd(RGC) pay dividends? If so, how much?
Regencell Bioscience Holdings Ltd(RGC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers